Profile for Inovio Pharmaceuticals Inc. (INO)

$ 8.12   -0.20 (-2.40%) Volume: 11.63m 4:00 PM EDT 9-Apr-2020
After Hours:  $ 8.14   0.02 (+0.25%) Volume: 90.65k 7:59 PM EDT 9-Apr-2020
Business Description:
Inovio Pharmaceuticals Inc is a clinical stage biopharmaceutical company. It develops active DNA immunotherapies and vaccines in combination with proprietary electroporation delivery devices to prevent and treat cancers and infectious diseases.
Address: 660 West Germantown Pike, Suite 110, Plymouth Meeting, PA, USA, 19462
Telephone: +1 267 440-4200 Website:
Facsimile: +1 267 440-4242 Email: [email protected]
CEO: J. Joseph Kim
Employees: 190 Market Cap: 1.18b
Issue Type: CS
Auditor: Ernst & Young LLP
Last Audit: Unqualified Opinion with Explanation
Indices: N/A
Industry Classifications
Sector: Healthcare CIK: 1055726
Industry: Biotechnology
Sub-Industry:    Biotechnology
NAICS: Biological Product (except Diagnostic) Manufacturing (325414)
SIC: Biological Products, Except Diagnostic Substances (2836)